1. Factors associated with severity of atopic dermatitis – a Finnish cross‐sectional study. (22nd July 2022) Authors: Salava, A.; Salo, V.; Leppänen, J.; Lauerma, A.; Remitz, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: 2130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Position statement: topical calcineurin inhibitors in atopic dermatitis. (6th November 2018) Authors: Remitz, A.; De Pità, O.; Mota, A.; Serra‐Baldrich, E.; Vakirlis, E.; Kapp, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 12(2018) Page Start: 2074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study. (13th January 2022) Authors: Salava, A.; Perälä, M.; Pelkonen, A.; Mäkelä, M.; Remitz, A. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 5(2022) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study. (1st May 2022) Authors: Salava, A.; Perälä, M.; Pelkonen, A.; Mäkelä, M.; Remitz, A. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 5(2022) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The spectrum of skin‐related conditions in primary care during 2015–2019–A Finnish nationwide database study. Issue 3 (5th June 2021) Authors: Salava, A.; Oker‐Blom, A.; Remitz, A. Journal: Skin health and disease Issue: Volume 1:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗